Moolchand Kurmi
Moolchand Kurmi
Senior Research Investigator at Biocon Bristol-Myers Squibb Research & Development Center (BBRC)
Verified email at syngeneintl.com
Title
Cited by
Cited by
Year
Forced degradation studies to assess the stability of drugs and products
S Singh, M Junwal, G Modhe, H Tiwari, M Kurmi, N Parashar, P Sidduri
TrAC Trends in Analytical Chemistry 49, 71-88, 2013
1382013
Implementation of design of experiments for optimization of forced degradation conditions and development of a stability-indicating method for furosemide
M Kurmi, S Kumar, B Singh, S Singh
Journal of pharmaceutical and biomedical analysis 96, 135-143, 2014
522014
Quality by design (QbD) in analytical sciences: an overview
H Bhutani, M Kurmi, S Singh, S Beg, B Singh
Quality Assurance 3, 39, 2004
442004
Stability behaviour of antiretroviral drugs and their combinations. 4: Characterization of degradation products of tenofovir alafenamide fumarate and comparison of its …
VM Golla, M Kurmi, K Shaik, S Singh
Journal of pharmaceutical and biomedical analysis 131, 146-155, 2016
272016
Stability behaviour of antiretroviral drugs and their combinations. 1: characterization of tenofovir disoproxil fumarate degradation products by mass spectrometry
M Kurmi, VM Golla, S Kumar, A Sahu, S Singh
RSC advances 5 (116), 96117-96129, 2015
182015
Stability behaviour of antiretroviral drugs and their combinations. 5: Characterization of novel degradation products of abacavir sulfate by mass and nuclear magnetic resonance …
M Kurmi, A Sahu, S Singh
Journal of pharmaceutical and biomedical analysis 134, 372-384, 2017
162017
Stability behaviour of antiretroviral drugs and their combinations. 8: Characterization and in-silico toxicity prediction of degradation products of efavirenz
M Kurmi, A Sahu, DK Singh, IP Singh, S Singh
Journal of pharmaceutical and biomedical analysis 148, 170-181, 2018
142018
Stability behaviour of antiretroviral drugs and their combinations. 3: characterization of interaction products of emtricitabine and tenofovir disoproxil fumarate by mass …
M Kurmi, DK Singh, S Tiwari, P Sharma, S Singh
Journal of pharmaceutical and biomedical analysis 128, 438-446, 2016
142016
Stability behaviour of antiretroviral drugs and their combinations. 2: characterization of interaction products of lamivudine and tenofovir disoproxil fumarate by mass and NMR …
M Kurmi, BS Kushwah, A Sahu, M Narayanam, S Singh
Journal of pharmaceutical and biomedical analysis 125, 245-259, 2016
142016
Quantitation of memantine hydrochloride bulk drug and its tablet formulation using proton nuclear magnetic resonance spectrometry
A Sahu, M Narayanam, M Kurmi, MK Ladumor, S Singh
Magnetic Resonance in Chemistry 54 (8), 632-636, 2016
122016
Stability behavior of antiretroviral drugs and their combinations. 7: Comparative degradation pathways of lamivudine and emtricitabine and explanation to their differential …
M Kurmi, S Singh
Journal of pharmaceutical and biomedical analysis 142, 155-161, 2017
102017
Stability behaviour of antiretroviral drugs and their combinations. 6: evidence of formation of potentially toxic degradation products of zidovudine under hydrolytic and …
M Kurmi, A Sahu, SK Tiwari, S Singh
RSC advances 7 (30), 18803-18814, 2017
72017
Stability behaviour of antiretroviral drugs and their combinations. 9: Identification of incompatible excipients
M Kurmi, A Sahu, MK Ladumor, AK Bansal, S Singh
Journal of pharmaceutical and biomedical analysis 166, 174-182, 2019
62019
LC–MS/TOF, LC–MSn and H/D Exchange Studies on Solifenacin Succinate Targeted to Characterize its Forced Degradation Products
DK Singh, M Kurmi, T Handa, S Singh
Chromatographia 79 (3-4), 159-168, 2016
62016
Characterization of forced degradation products of torasemide through MS tools and explanation of unusual losses observed during mass fragmentation of drug and degradation …
M Kurmi, N Patel, S Jhajra, PV Bharatam, S Singh
Journal of Pharmaceutical and Biomedical Analysis 145, 209-218, 2017
42017
Successful development by design of experiments of a gas chromatography method for simultaneous analysis of residual solvents of classes 1 and 2
KP Shah, S Kumar, M Kurmi, D Gohil, S Singh
Journal of chromatographic science 56 (6), 473-479, 2018
32018
Rapid and efficient chiral method development for lamivudine and tenofovir disoproxil fumarate fixed dose combination using ultra-high performance supercritical fluid …
M Kurmi, K Jayaraman, S Natarajan, GS Kumar, H Bhutani, L Bajpai
Journal of Chromatography A 1625, 461257, 2020
22020
Characterization of solution stress degradation products of aliskiren and prediction of their physicochemical and ADMET properties
BS Kushwah, J Gupta, DK Singh, M Kurmi, A Sahu, S Singh
European Journal of Pharmaceutical Sciences 121, 139-154, 2018
22018
Forced degradation of lafutidine and characterization of its non-volatile and volatile degradation products using LC-MS/TOF, LC-MS n and HS-GC-MS
SK Pravinchandra, M Kurmi, S Kumar, S Singh
New Journal of Chemistry 39 (12), 9679-9692, 2015
22015
Stability behaviour of antiretroviral drugs and their combinations. 11: Characterization of interaction products of zidovudine and efavirenz, and evaluation of their anti HIV-1 …
M Kurmi, A Sahu, A Balhara, IP Singh, S Kulkarni, NK Singh, P Garg, ...
Journal of pharmaceutical and biomedical analysis 178, 112911, 2020
12020
The system can't perform the operation now. Try again later.
Articles 1–20